Project Description

Botanisol’s Relief (TAI-LCx)

  • Natural Products
    One or more optimized & proven TAI-LCx variants ready for natural products/supplements (human & veterinary) markets.
  • Botanical Drug
    One or more TAI-LCx variants ready for human phase 1 & 2 clinical trials.
  • Small Molecule Discovery
    NIH Grant funded research.
  • Natural botanical derivative with high consumer acceptance
  • Inhibits multiple cytokines
  • No COX 1 or 2 inhibition (avoid cardio & gastro side effects)
  • Oral and topical products
  • Bioavailability and acute efficacy superior to turmeric and curcumin supplements
  • Inexpensive
  • Non-addictive.

How it works

Works by inhibiting multiple cytokine expression, including TNF-⍺. Concentrated active fraction to treat acute pain. Proven to reduce pain, swelling and redness caused by inflammation.

  • Natural Products:
    One or more optimized & proven TAI-LCx variants ready for natural products/supplements (human & veterinary) markets.
  • Botanical Drug:
    One or more TAI-LCx variants ready for human phase 1 & 2 clinical trials.
  • Small Molecule Discovery:
    NIH Grant funded research.